Products
Platform
Research
Market
Learn
Partner
Support
IPO

S

Sudeep Pharma Share Price

547.5
-15.05 (-2.68%)
SUDEEPPHRM • 20 Jan, 2026 | 10:59 AM
Buywith MTF at 3.33x leverage
The current prices are delayed, login or Open Demat Account for live prices.

Sudeep Pharma Stock Performance

1W Return-11.89
1Y Return0.00
Today's Low546.05
Prev. Close562.55
Mkt Cap (Cr.)6,353.93
1M Return-20.33
3Y Return0.00
52-Week High795
Open562.45
PE Ratio66.53
6M Return0.00
Today's High562.45
52-Week Low543.9
Face Value1

Sudeep Pharma Company background

Founded in: 1989
Managing director: Sujit J Bhayani
Sudeep Pharma Limited was incorporated as Sudeep Pharma Private Limited as a private limited company dated December 21, 1989, issued by the Registrar of Companies, Ahmedabad. Thereafter, Company was converted into a public limited company and the name of the Company was changed to Sudeep Pharma Limited pursuant to fresh certificate of incorporation dated April 5, 1995, issued by the Assistant Registrar of Companies, Gujarat at Dadra Nagar Haveli. Company was subsequently converted back to a private limited company vide a fresh certificate of incorporation dated October 1, 2014 issued by the Assistant Registrar of Companies, Gujarat at Ahmedabad, and the name of Company was accordingly changed from Sudeep Pharma Limited to Sudeep Pharma Private Limited. Further, Company was converted into a public limited company and consequently, the name of Company was changed to Sudeep Pharma Limited.The Company is one of the pioneers in India to introduce a product range of liposomal ingredients for nutrient absorption and stability. The Company is a technology led manufacturer of excipients and specialty ingredients for the pharmaceutical, food and nutrition industries. It operate three manufacturing facilities in Vadodara, Gujarat with an annual installed capacity of 65, 579 MT. Since inception in 1989, Company has expanded business operations from production of excipients to a wide variety of over 100 products in the pharmaceutical, food and nutrition industries. Business is primarily structured into two verticals: Pharmaceutical, food and nutrition and Specialty ingredients. The Company focus on providing refined, mineralbased single ingredients essential to the pharmaceutical, food, and nutrition industries.. Many of these minerals act as excipients, supporting the efficacy and stability of pharmaceutical formulations. Specialty ingredients entails production of customized ingredients to improve functionality, stability, and bioavailability across food and nutraceuticalapplications. These specialty ingredients play a key role in enhancing nutritional profiles, texture, and flavour across applications such as fortified dairy, beverages, and bakery products, as well as dietary supplements. Company is planning to launch the initial public offer by raising funds of Rs 95 Crore equity shares through fresh issue and by issuing 10,076,492equity shares, having the face value of Rs 1/ each via offer for sale.

Sudeep Pharma Financial Highlights


For the full year FY2025–2026, revenue reached ₹511.33 crore and profit touched at ₹138.69 crore. As of Dec '25, Sudeep Pharma’s market capitalisation stood at ₹6,353.93 crores. Shareholding as of Dec '25 shows promoters holding 76.2%, with FIIs at 1.7%, DIIs at 17.6%, and public at 4.6%.

Sudeep Pharma Share Price Today


As of 20 Jan 2026, Sudeep Pharma share price is ₹547.5. The stock opened at ₹562.4 and had closed at ₹562.6 the previous day. During today’s trading session, Sudeep Pharma share price moved between ₹546.05 and ₹562.45, with an average price for the day of ₹554.25. Over the last 52 weeks, the stock has recorded a low of ₹543.90 and a high of ₹795.00. In terms of performance, Sudeep Pharma share price has declined by 7.7% over the past six months and has declined by 24.25% over the last year.
Read More
View details of Market Depth

Sudeep Pharma Fundamental

Market Cap (in crs)

6,353.93

Face Value

1

Turnover (in lacs)

303.12

Key Metrics

Qtr Change %
-7.7
Dividend yield 1yr %
0

Sudeep Pharma Key Financials

View more
Loading chart...
Sudeep Pharma Quarterly Revenue
Sudeep Pharma Yearly Revenue
Sudeep Pharma Quarterly Net Profit/Loss
Sudeep Pharma Yearly Net Profit/Loss

Sudeep Pharma Result Highlights

  • Sudeep Pharma Ltd reported a 32.9% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a - of -.

  • Its expenses for the quarter were up by 31.7% QoQ and - - YoY.

  • The net profit increased 49.6% QoQ and - - YoY.

  • The earnings per share (EPS) of Sudeep Pharma Ltd stood at 4.2 during Q2 FY 2025-26.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Sudeep Pharma Shareholding Pattern

Promoter
76.2%
Foreign Institutions
1.7%
Mutual Funds
5.7%
Domestic Institutions
17.6%
Public
4.6%

Sudeep Pharma Technical Analysis

Moving Averages Analysis
547.5
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
9
Day EMA5
584.90
Day EMA10
591.60
Day EMA12
594.80
Day EMA20
609.60
Day EMA26
623.30
EMA
EMA
EMA
Delivery & Volume
Loading chart...

Day

37.80%

Week

16.70%

Month

30.40%

Delivery & Volume

567.15
Pivot
Resistance
First Resistance
574.30
Second Resistance
586.05
Third Resistance
593.20
Support
First Support
555.40
Second support
548.25
Third Support
536.50
Relative Strength Index
32.53
Money Flow Index
58.10
MACD
-27.25
MACD Signal
-30.29
Average True Range
29.27
Average Directional Index
34.89
Rate of Change (21)
-14.62
Rate of Change (125)
0.00
Compare

Sudeep Pharma Latest News

16 JAN 2026 | Friday
08 JAN 2026 | Thursday
26 DEC 2025 | Friday

Please be aware that Sudeep Pharma stock prices are subject to continuous fluctuations due to various factors.

Open Demat Account